Abstract
Kaposi’s sarcoma-associated herpesvirus (KSHV) is causally related to Kaposi’s sarcoma (KS), primary effusion lymphoma (PEL) and a proportion of cases of multicentric Castleman’s disease (MCD). The ORF73 protein was cloned into pQE80L-orf73 and expressed in E.coli and purified. The expressed recombinant ORF73 was identified by sodium dodecyl sulfatepolyacrylamide gel electrophoresis (SDS-PAGE). A protein of about 27 kDa was expressed as expected. Western Blotting showed that the purified recombinant ORF73 reacted with KSHV positive serum. The immunogenicity of the recombinant ORF73 was further analysed by ELISA and the optimal conditions were determined. The ORF73 ELISA was used to compare the KSHV seroprevalence between Hubei and Xinjiang Han people. The Han people in Xinjiang have significantly higher KSHV seroprevalence than their counterparts in Hubei (6.7% vs 2.9%, P = 0.005).
Similar content being viewed by others
References
Baillargeon J, Deng J H, Hettler E, et al. 2001. Seroprevalence of Kaposi’s sarcoma-associated herpesvirus infection among blood donors from Texas. Ann Epidemiol, 11: 512–518.
Cesarman E, Nador R G, Bai F, et al. 1996. Kaposi’s sarcoma-associated herpesvirus contains G protein-coupled receptor and cyclin D homologs which are expressed in Kaposi’s sarcoma and malignant lymphoma. J Virol, 70: 8218–8223.
Dukers N H, Rezza G. 2003. Human herpesvirus 8 epidemiology: what we do and do not know. Aids, 17: 1717–1730.
Fang Q, Liu J, Bai Z Q, et al. 2006. Seroprevalence of Kaposi’s sarcoma-associated herpesvirus in the central population from Hubei Province. Virol Sin, 21: 97–101.
Fu B, Li B, and Wang L. 2008. Immunogenicity Analysis of Prokaryotic Expression Products of KSHV orf65. Virol Sin, 23: 196–202.
Fu B, Sun F, Li B, et al. 2009. Seroprevalence of Kaposi’s sarcoma-associated herpesvirus and risk factors in Xinjiang, China. J Med Virol, 81: 1422–1431.
Fujii T, Taguchi H, Katano H, et al. 1999. Seroprevalence of human herpesvirus 8 in human immunodeficiency virus 1-positive and human immunodeficiency virus 1-negative populations in Japan. J Med Virol, 57: 159–162.
Gao S J, Kingsley L, Li M, et al. 1996. KSHV antibodies among Americans, Italians and Ugandans with and without Kaposi’s sarcoma. Nat Med, 2: 925–928.
Hall K T, Giles M S, Goodwin D J, et al. 2000. Characterization of the herpesvirus saimiri ORF73 gene product. J Gen Virol, 81: 2653–2658.
Juhasz A, Remenyik E, Konya J, et al. 2001. Prevalence and age distribution of human herpesvirus-8 specific antibodies in Hungarian blood donors. J Med Virol, 64: 526–530.
Kedes D H, Lagunoff M, Renne R, et al. 1997. Identification of the gene encoding the major latencyassociated nuclear antigen of the Kaposi’s sarcoma-associated herpesvirus. J Clin Invest, 100: 2606–2610.
Kellam P, Boshoff C, Whitby D, et al. 1997. Identification of a major latent nuclear antigen, LNA-1, in the human herpesvirus 8 genome. J Hum Virol, 1: 19–29.
Olsen S J, Sarid R, Chang Y, et al. 2000. Evaluation of the latency-associated nuclear antigen (ORF73) of Kaposi’s sarcoma-associated herpesvirus by peptide mapping and bacterially expressed recombinant western blot assay. J Infect Dis, 182: 306–310.
Perna A M, Bonura F, Vitale F, et al. 2000. Antibodies to human herpes virus type 8 (HHV8) in general population and in individuals at risk for sexually transmitted diseases in Western Sicily. Int J Epidemiol, 29: 175–179.
Rainbow L, Platt G M, Simpson G R, et al. 1997. The 222- to 234-kilodalton latent nuclear protein (LNA) of Kaposi’s sarcoma-associated herpesvirus (human herpesvirus 8) is encoded by orf73 and is a component of the latency-associated nuclear antigen. J Virol, 71: 5915–5921.
Schulz T F. 2000. Kaposi’s sarcoma-associated herpesvirus (human herpesvirus 8): epidemiology and pathogenesis. J Antimicrob Chemother, 45Suppl T3: 15–27.
Simpson G R, Schulz T F, Whitby D, et al. 1996. Prevalence of Kaposi’s sarcoma associated herpesvirus infection measured by antibodies to recombinant capsid protein and latent immunofluorescence antigen. Lancet, 348: 1133–1138.
Soulier J, Grollet L, Oksenhendler E, et al. 1995. Kaposi’s sarcoma-associated herpesvirus-like DNA sequences in multicentric Castleman’s disease. Blood, 86: 1276–1280.
Viejo-Borbolla A, Ottinger M, and Schulz T F. 2003. Human Herpesvirus 8: Biology and Role in the Pathogenesis of Kaposi’s Sarcoma and Other AIDS-related Malignancies. Curr Infect Dis Rep, 5: 169–175.
Wang L. 2007. Pathogenesis and Associated Disease of Kaposi’s Sarcoma-associated herpesvirus. Virol Sin, 22: 248–255.
Zhang D Z, Pu X M, Wu W D, et al. 2008. Genotypic analysis on the ORF-K1 gene of human herpesvirus 8 from patients with Kaposi’s sarcoma in Xinjiang, China. J Genet Genomics, 35: 657–663.
Author information
Authors and Affiliations
Corresponding authors
Additional information
Foundation items: Supported by the Research grants from Mega Scientific Project for HIV in China (2008ZX-10001-002), National Natural Science Foundation of Hubei Province (2008CDA013), the Scientific Research Foundation for the Returned Overseas Chinese Scholars, State Education Ministry, and National Institutes of Health (DE017333); Open Research Fund Program of the State Key Laboratory of Virology of China (2010012).
Rights and permissions
About this article
Cite this article
Ouyang, Xx., Fu, Bs., Li, Bl. et al. Establishment of an ELISA to detect Kaposi’s sarcoma-associated herpesvirus using recombinant ORF73. Virol. Sin. 25, 168–176 (2010). https://doi.org/10.1007/s12250-010-3106-4
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s12250-010-3106-4